AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$15.59
−0.03%Year over year
Reported trailing growth
- Revenue
- +0.9%
- EBITDA
- +41.1%
- EBIT
- +89.3%
- EPS
- +554.0%
- Free cash flow
- -16.1%
- Operating cash flow
- -9.3%
Forward estimates
Based on analyst estimates
- Revenue
- +2.3%
- EBITDA
- +40.7%
- EPS
- +74.8%
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -55.0%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -11.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026